Vivitrol | Addiction Professional Magazine Skip to content Skip to navigation

Vivitrol

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
article
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Opioid treatment programs growing, and expanding into other medications

August 23, 2017  |  Gary A. Enos, Editor
news
Today's opioid treatment programs (OTPs) are increasingly likely to be offering buprenorphine and injectable naltrexone treatment in addition to methadone.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Editor
article
The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

Could a device attached to the ear become a game-changer in detox?

April 12, 2017  |  Gary A. Enos, Editor
article
An electrical stimulation device that is approved for pain is gaining use as a method of easing withdrawal from opioids and facilitating access to longer-term treatment.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
news
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

App from SAMHSA guides medication treatment for opioid dependence

December 1, 2016  |  Gary A. Enos, Editor
news
The new MATx app is designed to share treatment strategies and other resources for the use of medications to treat opioid use disorders.

Health home model allows OTPs to cast a wider net

November 15, 2016  |  Rachael Zimlich, RN, Contributing Writer
article
Not only does the promising new health-home model require extra work in care coordination, it also requires a change in the way clinicians are thinking about care delivery.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
news
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.

Treatment behind the walls: States gather to share information

August 4, 2016  |  Alison Knopf, Contributing Writer
article
State correctional systems are gradually coming to realize that they can implement successful in-prison treatment programs with medication treatments at the center.

Study shows benefit from injectable naltrexone in justice population

March 30, 2016  |  Gary A. Enos, Editor
news
A study of 153 men found lower relapse rates among the group that received six monthly injections of Vivitrol, compared with a group receiving only motivational counseling and referral to community treatment.

Pages

Subscribe to Vivitrol